AlphaMaven AlphaMaven

Inside Cathie Wood’s ARK Innovation ETF: Tesla (TSLA), Coinbase, and AMD Lead the Pack

Reported by Mexc
May 12, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Tesla dominates ARK Innovation ETF (ARKK) with a 10.46% portfolio allocation, followed by Advanced Micro Devices at 5.66%, reflecting Wood's conviction in AI and semiconductor infrastructure exposure.
  • • ARKK's concentrated portfolio consists of 46 equities with the top 10 positions representing slightly over 51% of total assets, underscoring the fund's high-conviction investment approach.
  • • The fund maintains cryptocurrency infrastructure exposure through Coinbase and Robinhood holdings, positioning it for digital financial innovation.
  • • ARKK's investment thesis targets five core disruption themes: artificial intelligence and machine learning, genetic medicine, blockchain technology, financial technology innovation, and digital streaming platforms.
  • • Gene-editing leaders CRISPR Therapeutics and Beam Therapeutics highlight ARK's commitment to biotech as a transformative technology sector.
Summary
Cathie Wood's ARK Innovation ETF (ARKK) maintains its position as one of the most closely monitored growth-oriented investment vehicles in the institutional market. As of May 11, 2026, the fund manages a concentrated portfolio of 46 individual stocks with deliberate concentration—its top 10 holdings account for slightly over 51% of total assets, reflecting an explicit acceptance of volatility in exchange for exposure to disruptive technology sectors.

Tesla commands the largest position at 10.46% of the portfolio, remaining Wood's cornerstone holding due to its multifaceted exposure to electric transportation, autonomous driving technology, robotics development, and artificial intelligence capabilities. Advanced Micro Devices follows at 5.66%, providing the fund direct access to AI semiconductor technology and cloud computing infrastructure—sectors experiencing substantial growth as enterprise artificial intelligence investment accelerates globally.

Beyond traditional tech, ARKK maintains meaningful exposure to emerging financial infrastructure and biotechnology. Cryptocurrency market exposure comes through holdings in Coinbase and Robinhood, positioning the fund for potential growth in digital asset trading and blockchain-based financial services. In the biotech space, gene-editing companies CRISPR Therapeutics and Beam Therapeutics represent the fund's conviction in genetic medicine as a transformative healthcare category.

The fund's overarching investment thesis concentrates on five primary disruption vectors: artificial intelligence and machine learning systems, genetic medicine and therapeutic innovation, blockchain technology and cryptocurrency infrastructure, financial technology platforms, and emerging digital streaming and entertainment channels. This thematic approach allows ARKK to maintain sector diversification while maintaining a disciplined focus on companies positioned at the intersection of technological change and market opportunity.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Mexc Inside Cathie Wood’s ARK Innovation ETF: Tesla (TSLA), Coinbase, and AMD Lead the Pack